Why Boston Scientific (BSX) Stock Is Down Today

NEW YORK (TheStreet) -- Boston Scientific  (BSX) dipped Tuesday after medical device developer announced it would be "opportunistic" with regard to mergers and acquisitions.

The company said its two preferred uses of cash are share buybacks to return cash to shareholders and targeted M&A, according to TheFlyonTheWall. Boston Scientific said it will always be opportunistic with M&A and will always look to return cash to shareholders.

Furthermore, the company said it is focused on operating income and EPS growth and it feels "comfortable" with tax rate guidance.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The stock was down 2.32% to $12.62 at 10:40 a.m.

BSX Price Chart

BSX Price data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

These Stocks Are Ready to Reverse Course

Modi's Visit to Meet Trump Focuses Big Spotlight on the H-1B Visa Debate

Cramer: These Sectors Look Bullish (Part III)